Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK- 8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

Rockstroh JK, Nelson M, Katlama C, et al. Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK- 8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. Lancet HIV. 2015;2(8):e319-327.

Publication Type:

Journal Article

Authors:

J K Rockstroh; Nelson, M.; Katlama, C.; et, al

Source:

Lancet HIV, Volume 2, Issue 8, p.e319-327 (2015)

Cited On:

Export Citation:
RIS Format
Top